莱美药业
(300006)
| 流通市值：28.40亿 | | | 总市值：28.40亿 |
| 流通股本：10.56亿 | | | 总股本：10.56亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 181,120,476.19 | 895,592,665.42 | 644,756,058.18 | 453,859,975.46 |
| 营业收入 | 181,120,476.19 | 895,592,665.42 | 644,756,058.18 | 453,859,975.46 |
| 二、营业总成本 | 190,903,145.49 | 972,707,004.69 | 684,021,711.19 | 477,078,919.79 |
| 营业成本 | 63,725,646.12 | 274,678,187.58 | 198,114,541.29 | 136,263,746.34 |
| 税金及附加 | 4,115,543.26 | 19,418,955.68 | 14,388,027.79 | 10,038,295.81 |
| 销售费用 | 87,901,058.33 | 462,002,232.59 | 332,057,579.99 | 240,919,142.11 |
| 管理费用 | 30,292,810.48 | 139,406,060.27 | 103,673,404.05 | 69,609,191.75 |
| 研发费用 | 10,297,554.56 | 99,810,491.22 | 53,968,857 | 33,934,986.97 |
| 财务费用 | -5,429,467.26 | -22,608,922.65 | -18,180,698.93 | -13,686,443.19 |
| 其中:利息费用 | 2,570,705.62 | 12,471,274.11 | 9,591,763.02 | 6,606,408.03 |
| 其中:利息收入 | 7,956,018.13 | 34,636,239.99 | 27,035,213.71 | 19,377,078.67 |
| 加:投资收益 | -5,537,147.83 | 87,019,510.13 | 722,553.22 | -1,601,618.43 |
| 资产处置收益 | 8,006.35 | 446,091.9 | - | - |
| 资产减值损失(新) | -110,828.74 | -5,042,469.07 | -3,701,592.39 | -2,729,350.97 |
| 信用减值损失(新) | -2,640,184.15 | -3,662,220.43 | -8,260,187.81 | -6,474,000.84 |
| 其他收益 | 19,870,791.47 | 54,580,115.74 | 37,709,326.78 | 19,570,515.13 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 1,807,967.8 | 56,226,689 | -12,795,553.21 | -14,453,399.44 |
| 加:营业外收入 | 4,271.79 | 328,302.62 | 79,543.56 | 3,365.62 |
| 减:营业外支出 | 43,699.1 | 52,960,651.99 | 52,279,931.87 | 52,042,130.07 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 1,768,540.49 | 3,594,339.63 | -64,995,941.52 | -66,492,163.89 |
| 减:所得税费用 | 1,737,162.49 | 13,612,118.73 | -1,029,731.9 | -3,434,290.46 |
| 六、净利润 | 31,378 | -10,017,779.1 | -63,966,209.62 | -63,057,873.43 |
| 持续经营净利润 | 31,378 | -10,017,779.1 | -63,966,209.62 | -63,057,873.43 |
| 归属于母公司股东的净利润 | -4,575,299.38 | -8,927,328.47 | -54,513,800.64 | -54,056,871.17 |
| 少数股东损益 | 4,606,677.38 | -1,090,450.63 | -9,452,408.98 | -9,001,002.26 |
| (一)基本每股收益 | 0 | -0.01 | -0.05 | -0.05 |
| (二)稀释每股收益 | 0 | -0.01 | -0.05 | -0.05 |
| 八、其他综合收益 | - | -43,771,919.62 | - | - |
| 归属于母公司股东的其他综合收益 | - | -43,771,919.62 | - | - |
| 九、综合收益总额 | 31,378 | -53,789,698.72 | -63,966,209.62 | -63,057,873.43 |
| 归属于母公司股东的综合收益总额 | -4,575,299.38 | -52,699,248.09 | -54,513,800.64 | -54,056,871.17 |
| 归属于少数股东的综合收益总额 | 4,606,677.38 | -1,090,450.63 | -9,452,408.98 | -9,001,002.26 |
| 公告日期 | 2024-04-24 | 2024-03-23 | 2023-10-21 | 2023-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |